---
title: Biotest Facility vs Sciomics GmbH
slug_a: bioxpedia
slug_b: sciomics
site: cro
review_signal_gate: closed
canonical_path: /compare/bioxpedia/sciomics
---

# Biotest Facility vs Sciomics GmbH

Side-by-side profile data from each company listing on this directory.

## Biotest Facility

- Profile: [/companies/bioxpedia](/companies/bioxpedia)

Biotest Facility — Danish CRO offering in vivo models, proteomics, transcriptomics, biomarker discovery, and bioinformatics to support biotech and pharma research from concept to validated data.

Services: 16. Modalities: 2. Indications: 5. Locations: 3. Certifications: 1. The strongest documented coverage currently appears in services (16).

### Services

- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Biomarker Assays
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Translational Research
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Small Molecule
- Peptide

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## Sciomics GmbH

- Profile: [/companies/sciomics](/companies/sciomics)

Sciomics GmbH — Sciomics provides antibody microarray proteomics, with panels profiling hundreds to over 1,500 proteins and PTMs from minimal sample input. Its services support biomarker discovery, target validation, and patient stratification for pharma and biotech partners.

Services: 5. Modalities: 0. Indications: 1. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Target Identification & Validation
- Biomarker Assays
- Translational Research
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Data not yet provided.

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Data not yet provided.